Insider Buy/Sell Details for the Biotechnology Industry — August 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (114)
Camp4 Therapeutics Corp (CAMP)
Gold Kelly — Chief Financial Officer
Shares
10,000
Price
$3.96
Total Value
$39.60K
Shares Held After
10,000
% of Holdings
100.0%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
403,571
Price
$1.79
Total Value
$722.59K
Shares Held After
5,257,389
% of Holdings
7.7%
Emmaus Life Sciences, Inc. (EMMA)
LEE WILLIS C — Director
Shares
100,000
Price
$0.05
Total Value
$5.00K
Shares Held After
690,167
% of Holdings
14.5%
Quoin Pharmaceuticals, Ltd. (QNRX)
Carter Denise P. — Director
Shares
20,490
Price
$4.88
Total Value
$99.99K
Shares Held After
37,709
% of Holdings
54.3%
Quoin Pharmaceuticals, Ltd. (QNRX)
Myers Michael — Director
Shares
20,490
Price
$4.88
Total Value
$99.99K
Shares Held After
37,713
% of Holdings
54.3%
Quoin Pharmaceuticals, Ltd. (QNRX)
Lawlor Sally Bridget — Chief Financial Officer
Shares
10,244
Price
$4.88
Total Value
$49.99K
Shares Held After
10,684
% of Holdings
95.9%
Quoin Pharmaceuticals, Ltd. (QNRX)
Culverwell Anthony James — Director
Shares
6,146
Price
$4.88
Total Value
$29.99K
Shares Held After
40,364
% of Holdings
15.2%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
217
Price
$69.10
Total Value
$14.99K
Shares Held After
525,217
% of Holdings
0.0%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
5,000
Price
$68.23
Total Value
$341.18K
Shares Held After
525,000
% of Holdings
1.0%
Emmaus Life Sciences, Inc. (EMMA)
LEE WILLIS C — Director
Shares
94,767
Price
$0.06
Total Value
$5.69K
Shares Held After
590,167
% of Holdings
16.1%
MAIA Biotechnology, Inc. (MAIA)
Guerrero Ramiro — Director
Shares
46,620
Price
$1.35
Total Value
$62.94K
Shares Held After
735,701
% of Holdings
6.3%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
5,000
Price
$68.81
Total Value
$344.05K
Shares Held After
520,000
% of Holdings
1.0%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
20,113
Price
$68.42
Total Value
$1.38M
Shares Held After
515,000
% of Holdings
3.9%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
10,000
Price
$71.40
Total Value
$713.97K
Shares Held After
494,887
% of Holdings
2.0%
BIOVIE INC. (BIVI)
Chappell Amy Suzon — Director
Shares
727
Price
$2.16
Total Value
$1.57K
Shares Held After
727
% of Holdings
100.0%
BIOVIE INC. (BIVI)
KIM JOANNE WENDY — Chief Financial Officer
Shares
2,500
Price
$2.18
Total Value
$5.45K
Shares Held After
3,441
% of Holdings
72.7%
BIOVIE INC. (BIVI)
Palumbo Joseph M — Chief Medical Officer
Shares
4,843
Price
$2.16
Total Value
$10.46K
Shares Held After
6,036
% of Holdings
80.2%
Emmaus Life Sciences, Inc. (EMMA)
LEE WILLIS C — Director
Shares
50,000
Price
$0.05
Total Value
$2.50K
Shares Held After
495,400
% of Holdings
10.1%
MAIA Biotechnology, Inc. (MAIA)
Guerrero Ramiro — Director
Shares
78,239
Price
$1.39
Total Value
$108.75K
Shares Held After
689,081
% of Holdings
11.4%
Tonix Pharmaceuticals Holding Corp. (TNXP)
LEDERMAN SETH — Director
Shares
2,000
Price
$13.79
Total Value
$27.58K
Shares Held After
11,005
% of Holdings
18.2%
BIOVIE INC. (BIVI)
DO CUONG V — Director
Shares
15,210
Price
$2.08
Total Value
$31.64K
Shares Held After
16,117
% of Holdings
94.4%
REGENXBIO Inc. (RGNX)
Ciongoli Gregory Austin — Director
Shares
53,407
Price
$9.36
Total Value
$499.68K
Shares Held After
118,035
% of Holdings
45.2%
EXOZYMES INC. (EXOZ)
Heltzen Michael — Chief Executive Officer
Shares
250
Price
$7.60
Total Value
$1.90K
Shares Held After
14,453
% of Holdings
1.7%
EXOZYMES INC. (EXOZ)
Heltzen Michael — Chief Executive Officer
Shares
251
Price
$7.35
Total Value
$1.84K
Shares Held After
14,704
% of Holdings
1.7%
EXOZYMES INC. (EXOZ)
Heltzen Michael — Chief Executive Officer
Shares
4
Price
$7.58
Total Value
$30.32
Shares Held After
14,708
% of Holdings
0.0%
MAIA Biotechnology, Inc. (MAIA)
Guerrero Ramiro — Director
Shares
8,931
Price
$1.39
Total Value
$12.41K
Shares Held After
610,842
% of Holdings
1.5%
Orchestra BioMed Holdings, Inc. (OBIO)
Sherman Darren — Director
Shares
2,000
Price
$5.33
Total Value
$10.66K
Shares Held After
2,000
% of Holdings
100.0%
REGENXBIO Inc. (RGNX)
Ciongoli Gregory Austin — Director
Shares
49,196
Price
$9.14
Total Value
$449.71K
Shares Held After
64,628
% of Holdings
76.1%
Immatics N.V. (IMTX)
PERCEPTIVE ADVISORS LLC — Director
Shares
863,060
Price
$8.69
Total Value
$7.50M
Shares Held After
11,246,516
% of Holdings
7.7%
EXOZYMES INC. (EXOZ)
Heltzen Michael — Chief Executive Officer
Shares
100
Price
$7.50
Total Value
$750.00
Shares Held After
13,953
% of Holdings
0.7%
EXOZYMES INC. (EXOZ)
Heltzen Michael — Chief Executive Officer
Shares
250
Price
$7.52
Total Value
$1.88K
Shares Held After
14,203
% of Holdings
1.8%
Emmaus Life Sciences, Inc. (EMMA)
LEE WILLIS C — Director
Shares
46,000
Price
$0.04
Total Value
$1.84K
Shares Held After
445,400
% of Holdings
10.3%
CEL SCI CORP (CVM)
KERSTEN GEERT R — Director
Shares
100,000
Price
$1.38
Total Value
$138.00K
Shares Held After
316,142
% of Holdings
31.6%
MAIA Biotechnology, Inc. (MAIA)
Guerrero Ramiro — Director
Shares
1,794
Price
$1.33
Total Value
$2.39K
Shares Held After
601,911
% of Holdings
0.3%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
107,374
Price
$1.75
Total Value
$188.36K
Shares Held After
4,853,818
% of Holdings
2.2%
AbCellera Biologics Inc. (ABCL)
Hayden Michael R — Director
Shares
53,613
Price
$10.64
Total Value
$570.44K
Shares Held After
1,373,397
% of Holdings
3.9%
Kura Oncology, Inc. (KURA)
WILSON TROY EDWARD — Director
Shares
100,000
Price
$12.39
Total Value
$1.24M
Shares Held After
479,194
% of Holdings
20.9%
PRECIGEN, INC. (PGEN)
AGEE NANCY H — Director
Shares
3,411
Price
$7.23
Total Value
$24.66K
Shares Held After
309,187
% of Holdings
1.1%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
716,369
Price
$1.77
Total Value
$1.27M
Shares Held After
4,746,444
% of Holdings
15.1%
Protagenic Therapeutics, Inc.\new (PTIX)
ARMEN GARO H — Director
Shares
20,000
Price
$0.65
Total Value
$13.00K
Shares Held After
73,533
% of Holdings
27.2%
MAIA Biotechnology, Inc. (MAIA)
Guerrero Ramiro — Director
Shares
11,899
Price
$1.37
Total Value
$16.30K
Shares Held After
600,117
% of Holdings
2.0%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
202,124
Price
$1.78
Total Value
$359.54K
Shares Held After
4,030,075
% of Holdings
5.0%
Tonix Pharmaceuticals Holding Corp. (TNXP)
BAGGER RICHARD H — Director
Shares
1,000
Price
$12.60
Total Value
$12.60K
Shares Held After
1,000
% of Holdings
100.0%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
50,000
Price
$8.79
Total Value
$439.43K
Shares Held After
800,000
% of Holdings
6.2%
Protagenic Therapeutics, Inc.\new (PTIX)
ARMEN GARO H — Director
Shares
16,634
Price
$0.59
Total Value
$9.81K
Shares Held After
53,533
% of Holdings
31.1%
Protagenic Therapeutics, Inc.\new (PTIX)
ARMEN GARO H — Director
Shares
2,700
Price
$0.35
Total Value
$945.00
Shares Held After
36,899
% of Holdings
7.3%
Phio Pharmaceuticals Corp. (PHIO)
Plott Ronald Todd — Director
Shares
15,000
Price
$1.14
Total Value
$17.10K
Shares Held After
15,000
% of Holdings
100.0%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
CHEN THOMAS C — Director
Shares
12,757
Price
$5.49
Total Value
$70.00K
Shares Held After
13,705
% of Holdings
93.1%
Z Squared Inc. (ZSQR)
Schadel Christopher Ryan — Chief Marketing Officer
Shares
1,000
Price
$3.92
Total Value
$3.92K
Shares Held After
1,000
% of Holdings
100.0%
Phio Pharmaceuticals Corp. (PHIO)
Bitterman Robert J — Director
Shares
10,000
Price
$1.06
Total Value
$10.60K
Shares Held After
431,421
% of Holdings
2.3%
Showing 1–50 of 114 transactions (page 1 of 3)